Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hearne Michael S
Relationship:   Chief Financial Officer
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   2,620    

Indirect Shares

   12,767,435      
Direct Value   $7,465,690    

Indirect Value

   $36,380,806,033      
Total Shares   12,770,055      
Total Value   $36,388,271,723      


Odonate Therapeutics Inc $7,465,690 Odonate Therapeutics Inc $7,465,690
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    20   
    3    

     Stock price went up :
    10   
    0    
     Stock price went down :
    10   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
   -17.1%
 -97.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Odonate Therapeutics Inc ODT Chief Financial Officer 2021-03-15 2,620 2021-11-19 12,767,435    Premium*  
            La Jolla Pharmaceutical Co LJPC Chief Financial Officer 2022-08-22 0 2022-08-22 0    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-06-04 4 B $4.94 $1,065,636 I/I 215,812 8,695,474 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-08-12 4 B $3.47 $150,820 I/I 43,513 8,738,987 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-08-13 4 B $3.65 $800,586 I/I 219,465 8,958,452 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-08-14 4 B $3.88 $653,694 I/I 168,669 9,127,121 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-09-04 4 B $3.82 $258,359 I/I 67,552 9,194,673 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-09-08 4 B $3.90 $328,529 I/I 84,152 9,278,825 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2020-09-09 4 B $4.01 $509,940 I/I 126,665 9,405,490 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-05-24 4 B $3.68 $384,234 I/I 104,403 9,509,893 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-05-25 4 B $3.77 $482,734 I/I 127,379 9,637,272 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-05-26 4 B $4.26 $710,763 I/I 166,932 9,804,204 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-05-27 4 B $4.47 $831,762 I/I 185,928 9,990,132 1.99 %
LJPC La Jolla Pharmaceutical C... Chief Financial Officer   •       –      –    2021-06-01 4 B $4.29 $263,931 I/I 59,092 10,049,224 1.99 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-06 4 B $14.62 $153,573 I/I 10,500 12,752,838 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-07 4 B $14.98 $142,291 I/I 9,500 12,762,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2021-11-19 4 S $1.92 $699,930 I/I (365,289) 12,767,435 0 %
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-11 4 B $15.25 $83,128 I/I 5,450 12,767,788 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-12 4 B $15.65 $228,946 I/I 14,550 12,782,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-14 4 B $15.08 $150,838 I/I 10,000 12,792,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-17 4 B $14.51 $268,612 I/I 18,296 12,810,634 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-18 4 B $14.13 $167,189 I/I 11,704 12,822,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-20 4 B $13.17 $131,742 I/I 10,000 12,832,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-21 4 B $12.27 $255,828 I/I 20,000 12,852,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-26 4 B $12.09 $368,287 I/I 30,000 12,882,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-27 4 B $12.03 $120,315 I/I 10,000 12,892,338 1.99 -
ODT Odonate Therapeutics Inc Chief Financial Officer   •       –      –    2018-12-28 4 B $12.04 $253,863 I/I 20,000 12,912,338 1.99 -
  145  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us